Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
TRICARE covers Zepbound when prescribed for type 2 diabetes, provided you meet clinical criteria including HbA1c of 7.0% or higher and documented failure of metformin plus at least one other diabetes medication
FDA Registration number: DRP-16257-01
Weight loss is about more than just shedding poundsits about feeling your best, gaining confidence, and improving overall health
Learn about Retatrutide (GGG tri-agonist) medication Retatrutide is an up and coming medication, still in clinical trials and does not yet have a known time when it will be approved for use or available to the general public
Ozempic uses semaglutide, a GLP-1 medicine taken as a once-weekly injection
